A research team at Washington University in St. Louis tested a psychedelic that acts on serotonin. Serotonin helps control the widening and narrowing of blood vessels, so the team wanted to see if blood-flow signals still match neural activity.
In mice given the drug, blood flow did not change in the usual way when neurons were active. A second medication that blocks a specific serotonin receptor removed those unusual blood-flow effects. The researchers then used psilocybin in more mouse experiments and reanalyzed human fMRI data; both showed comparable changes. The finding means blood flow–based scans may not always show true neural activity after psychedelics.
Difficult words
- psychedelic — a drug that changes perception and thinking
- serotonin — a chemical in the body that affects blood vessels
- receptor — a protein on cells that receives signals
- psilocybin — a psychedelic compound found in some mushrooms
- blood flow — movement of blood through body vesselsblood-flow
- neural — related to nerves or brain cells
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Discussion questions
- Why did the researchers test the drug in mice?
- How could changes in blood flow affect brain scans?
- Have you seen a brain scan before? How did it seem to you?
Related articles
Untreated Sleep Apnea Speeds Heart Aging and Raises Death Risk
A laboratory study using a long-term mouse model finds that untreated obstructive sleep apnea — recreated by repeated drops in oxygen during sleep — leads to faster cardiovascular aging and higher mortality. Researchers call for early screening and treatment.
Engineered antibodies could block cytomegalovirus
A research team created changed antibodies that stop human cytomegalovirus from disabling immune responses. Lab tests show the antibodies reduce virus spread, but researchers say more testing is needed before they can be used in people.
